AbbVie (ABBV) Non-cash Items (2013 - 2016)
AbbVie (ABBV) reported Non-cash Items of $576.0 million for Q2 2016, down 38.72% year-over-year from $940.0 million in Q3 2015, and up 2913.03% quarter-over-quarter from $19.1 million in Q1 2016.
AbbVie (ABBV) Non-cash Items (2013 - 2016) Analysis & Trends
AbbVie (ABBV) has 4 years of Non-cash Items data on file, last reported at $576.0 million in Q2 2016.
- Non-cash Items for Q2 2016 came in at $576.0 million, down 38.72% year-over-year; the trailing twelve-month figure through Jun 2016 was $576.0 million (down 38.72% YoY), and the FY2015 annual result was $21.1 million, down 97.98% from the prior year.
- Non-cash Items climbed to $576.0 million in Q2 2016 per ABBV's latest filing, from $19.1 million in the prior quarter.
- Over five years, Non-cash Items peaked at $1.0 billion in Q4 2014 and troughed at $5.0 million in Q1 2014.
- A 4-year average of $525.3 million and a median of $633.0 million in 2015 frame the typical range for Non-cash Items.
- On a YoY basis, Non-cash Items climbed as much as 2255.43% in 2014 and fell as far as 88.14% in 2014.
- A 4-year view of Non-cash Items shows it stood at $912.0 million in 2013, then advanced by 14.47% to $1.0 billion in 2014, then slumped by 35.44% to $674.0 million in 2015, then fell by 14.54% to $576.0 million in 2016.
- Business Quant data shows ABBV's Non-cash Items at $576.0 million in Q2 2016, $19.1 million in Q1 2016, and $674.0 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 576.00 Mn |
| Jun 30, 2016 | 576.00 Mn |
| Mar 31, 2016 | 19.12 Mn |
| Mar 31, 2016 | 19.12 Mn |
| Dec 31, 2015 | 674.00 Mn |
| Dec 31, 2015 | 674.00 Mn |
| Sep 30, 2015 | 592.00 Mn |
| Sep 30, 2015 | 592.00 Mn |
| Jun 30, 2015 | 940.00 Mn |
| Jun 30, 2015 | 940.00 Mn |
| Mar 31, 2015 | 8.00 Mn |
| Mar 31, 2015 | 8.00 Mn |
| Dec 31, 2014 | 1.04 Bn |
| Dec 31, 2014 | 1.04 Bn |
| Sep 30, 2014 | 914.00 Mn |
| Sep 30, 2014 | 914.00 Mn |
| Jun 30, 2014 | 912.00 Mn |
| Jun 30, 2014 | 912.00 Mn |
| Mar 31, 2014 | 5.00 Mn |
| Mar 31, 2014 | 5.00 Mn |